Global Central Nervous System Drugs Market Research Report 2016 Chapter 1 Central Nervous System Drugs Market Overview 1.1 Product Overview and Scope of Central Nervous System Drugs 1.2 Central Nervous System Drugs Market Segmentation by Type 1.2.1 Global Production Market Share of Central Nervous System Drugs by Type in 2015 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Central Nervous System Drugs Market Segmentation by Application 1.3.1 Central Nervous System Drugs Consumption Market Share by Application in 2015 1.3.2 Application I 1.3.3 Application II 1.3.4 Application III 1.4 Central Nervous System Drugs Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Central Nervous System Drugs (2011-2021) Chapter 2 Global Economic Impact on Central Nervous System Drugs Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions 2.3 Effects to Central Nervous System Drugs Industry Chapter 3 Global Central Nervous System Drugs Market Competition by Manufacturers 3.1 Global Central Nervous System Drugs Production and Share by Manufacturers (2015 and 2016) 3.2 Global Central Nervous System Drugs Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Central Nervous System Drugs Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Central Nervous System Drugs Manufacturing Base Distribution, Sales Area and Product Type 3.5 Central Nervous System Drugs Market Competitive Situation and Trends 3.5.1 Central Nervous System Drugs Market Concentration Rate 3.5.2 Central Nervous System Drugs Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Central Nervous System Drugs Production, Revenue (Value) by Region (2011-2016) 4.1 Global Central Nervous System Drugs Production by Region (2011-2016) 4.2 Global Central Nervous System Drugs Production Market Share by Region (2011-2016) 4.3 Global Central Nervous System Drugs Revenue (Value) and Market Share by Region (2011-2016) 4.4 Global Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.5 North America Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.6 Europe Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.7 China Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.8 Japan Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.9 Southeast Asia Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) 4.10 India Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016) Chapter 5 Global Central Nervous System Drugs Supply (Production), Consumption, Export, Import by Regions (2011-2016) 5.1 Global Central Nervous System Drugs Consumption by Regions (2011-2016) 5.2 North America Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) 5.3 Europe Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) 5.4 China Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) 5.5 Japan Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) 5.6 Southeast Asia Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) 5.7 India Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016) Chapter 6 Global Central Nervous System Drugs Production, Revenue (Value), Price Trend by Type 6.1 Global Central Nervous System Drugs Production and Market Share by Type (2011-2016) 6.2 Global Central Nervous System Drugs Revenue and Market Share by Type (2011-2016) 6.3 Global Central Nervous System Drugs Price by Type (2011-2016) 6.4 Global Central Nervous System Drugs Production Growth by Type (2011-2016) Chapter 7 Global Central Nervous System Drugs Market Analysis by Application 7.1 Global Central Nervous System Drugs Consumption and Market Share by Application (2011-2016) 7.2 Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Central Nervous System Drugs Manufacturers Analysis 8.1 Johnson & Johnson 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.1.4 Business Overview 8.2 Pfizer 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.2.4 Business Overview 8.3 Novartis 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.3.4 Business Overview 8.4 Roche 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.4.4 Business Overview 8.5 Sanofi-Aventis 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.5.4 Business Overview 8.6 Merck 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.6.4 Business Overview 8.7 GSK 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.7.4 Business Overview 8.8 Bayer Schering 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.8.4 Business Overview 8.9 Bristol-Myers Squibb 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.9.4 Business Overview 8.10 AbbVie 8.10.1 Company Basic Information, Manufacturing Base and Competitors 8.10.2 Product Type, Application and Specification 8.10.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.10.4 Business Overview 8.11 Eli Lilly 8.12 AstraZeneca 8.13 Takeda 8.14 Actavis 8.15 Astellas Pharma US 8.16 Teva 8.17 Biogen 8.18 Shire  … Chapter 9 Central Nervous System Drugs Manufacturing Cost Analysis 9.1 Central Nervous System Drugs Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Central Nervous System Drugs Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Central Nervous System Drugs Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Analysis of Investment Strategy 11.1 Industry Development Characters 11.1.1 Periodicity of the industry 11.1.2 Regional traits of the industry 11.1.3 Upstream and downstream of Central Nervous System Drugs industry 11.1.4 Operational mode of the industry 11.2 Analysis of Investment Situation of Central Nervous System Drugs Industry 11.2.1 Development Pattern 11.2.2 Entry Barrier 11.2.3 Industrial SWOT Analysis 11.2.4 Analysis of Industrial Five Forces Mode 11.3 Analysis of Development Trend Chapter 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List Chapter 13 Market Effect Factors Alysis 13.1 Technology Progress/Risk 13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change Chapter 14 Global Central Nervous System Drugs Market Forecast (2016-2021) 14.1 Global Central Nervous System Drugs Production, Revenue Forecast (2016-2021) 14.2 Global Central Nervous System Drugs Production, Consumption Forecast by Regions (2016-2021) 14.3 Global Central Nervous System Drugs Production Forecast by Type (2016-2021) 14.4 Global Central Nervous System Drugs Consumption Forecast by Application (2016-2021) 14.5 Central Nervous System Drugs Price Forecast (2016-2021) Chapter 15 Research Findings and Conclusion Chapter 16 Appendix Author List Disclosure Section Research Methodology Data Source China Disclaimer

List of Figures Figure Picture of Central Nervous System Drugs Figure Global Production Market Share of Central Nervous System Drugs by Type in 2015 Figure Application of Central Nervous System Drugs Figure North America Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure Europe Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure China Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure Japan Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure Southeast Asia Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure India Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021) Figure Global Central Nervous System Drugs Revenue (Million UDS) and Growth Rate (2011-2021) Figure Global Central Nervous System Drugs Capacity of Key Manufacturers in 2015 Figure Global Central Nervous System Drugs Capacity of Key Manufacturers in 2016 Figure 2015 Central Nervous System Drugs Production Share by Manufacturers Figure 2016 Central Nervous System Drugs Production Share by Manufacturers Figure Global Market Central Nervous System Drugs Average Price of Key Manufacturers in 2015 Figure Central Nervous System Drugs Market Share of Top 3 Manufacturers Figure Central Nervous System Drugs Market Share of Top 5 Manufacturers Figure Global Central Nervous System Drugs Capacity Market Share by Regions (2011-2016) Figure Global Central Nervous System Drugs Capacity Market Share by Regions (2011-2016) Figure 2015 Global Central Nervous System Drugs Capacity Market Share by Regions Figure Global Central Nervous System Drugs Production and Market Share by Regions (2011-2016) Figure Global Central Nervous System Drugs Production Market Share by Regions (2011-2016) Figure 2015 Global Central Nervous System Drugs Production Market Share by Regions Figure Global Central Nervous System Drugs Consumption Market Share by Regions (2011-2016) Figure 2015 Global Central Nervous System Drugs Consumption Market Share by Regions Figure Production Market Share of Central Nervous System Drugs by Type (2011-2016) Figure 2015 Production Market Share of Central Nervous System Drugs by Type Figure Production Revenue Share of Central Nervous System Drugs by Type (2011-2016) Figure 2015 Revenue Market Share of Central Nervous System Drugs by Type Figure Global Central Nervous System Drugs Production Growth by Type (2011-2016) Figure Global Central Nervous System Drugs Consumption Market Share by Application in 2015 Figure Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016) List of Tables Table Product Overview and Scope of Central Nervous System Drugs Table Major Manufacturers of Type I Table Major Manufacturers of Type II Table Major Manufacturers of Type III Table Central Nervous System Drugs Consumption Market Share by Application in 2015 Table Global Central Nervous System Drugs Capacity of Key Manufacturers (2015 and 2016) Table Global Central Nervous System Drugs Capacity Market Share by Manufacturers (2015 and 2016) Table Global Central Nervous System Drugs Production of Key Manufacturers (2015 and 2016) Table Global Central Nervous System Drugs Production Share by Manufacturers (2015 and 2016) Table Global Central Nervous System Drugs Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Central Nervous System Drugs Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Central Nervous System Drugs Revenue Share by Manufacturers Table 2016 Global Central Nervous System Drugs Revenue Share by Manufacturers Table Global Market Central Nervous System Drugs Average Price of Key Manufacturers (2015 and 2016) Table Manufacturers Central Nervous System Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Central Nervous System Drugs Product Type Table Global Central Nervous System Drugs Capacity by Regions (2011-2016) Table Global Central Nervous System Drugs Production by Regions (2011-2016) Table Global Central Nervous System Drugs Revenue by Regions (2011-2016) Table Global Central Nervous System Drugs Revenue Market Share by Regions (2011-2016) Table 2015 Global Central Nervous System Drugs Revenue Market Share by Regions Table Global Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table North America Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Europe Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table China Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Japan Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Southeast Asia Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table India Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Global Central Nervous System Drugs Consumption Market by Regions (2011-2016) Table Global Central Nervous System Drugs Consumption Market Share by Regions (2011-2016) Table North America Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table Europe Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table China Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table Japan Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table Southeast Asia Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table India Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016) Table Global Central Nervous System Drugs Production by Type (2011-2016) Table Global Central Nervous System Drugs Production Share by Type (2011-2016) Table Global Central Nervous System Drugs Revenue by Type (2011-2016) Table Global Central Nervous System Drugs Revenue Share by Type (2011-2016) Table Global Central Nervous System Drugs Price by Type (2011-2016) Table Global Central Nervous System Drugs Consumption by Application (2011-2016) Table Global Central Nervous System Drugs Consumption Market Share by Application (2011-2016) Table Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Johnson & Johnson Central Nervous System Drugs Global Market Share (2011-2016) Table Pfizer Basic Information List Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Pfizer Central Nervous System Drugs Global Market Share (2011-2016) Table Novartis Basic Information List Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Novartis Central Nervous System Drugs Global Market Share (2011-2016) Table Roche Basic Information List Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Roche Central Nervous System Drugs Global Market Share (2011-2016) Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Sanofi-Aventis Central Nervous System Drugs Global Market Share (2011-2016) Table Merck Basic Information List Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Merck Central Nervous System Drugs Global Market Share (2011-2016) Table GSK Basic Information List Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure GSK Central Nervous System Drugs Global Market Share (2011-2016) Table Bayer Schering Basic Information List Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Bayer Schering Central Nervous System Drugs Global Market Share (2011-2016) Table Bristol-Myers Squibb Basic Information List Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Bristol-Myers Squibb Central Nervous System Drugs Global Market Share (2011-2016) Table AbbVie Basic Information List Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure AbbVie Central Nervous System Drugs Global Market Share (2011-2016) Table Eli Lilly Basic Information List Table Eli Lilly Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Eli Lilly Central Nervous System Drugs Global Market Share (2011-2016) Table AstraZeneca Basic Information List Table AstraZeneca Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure AstraZeneca Central Nervous System Drugs Global Market Share (2011-2016) Table Takeda Basic Information List Table Takeda Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Takeda Central Nervous System Drugs Global Market Share (2011-2016) Table Actavis Basic Information List Table Actavis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Actavis Central Nervous System Drugs Global Market Share (2011-2016) Table Astellas Pharma US Basic Information List Table Astellas Pharma US Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Astellas Pharma US Central Nervous System Drugs Global Market Share (2011-2016) Table Teva Basic Information List Table Teva Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Teva Central Nervous System Drugs Global Market Share (2011-2016) Table Biogen Basic Information List Table Biogen Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Biogen Central Nervous System Drugs Global Market Share (2011-2016) Table Shire Basic Information List Table Shire Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016) Figure Shire Central Nervous System Drugs Global Market Share (2011-2016) Table Production Base and Market Concentration Rate of Raw Material Table Key Suppliers of Raw Materials Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015 Table Major Buyers of Central Nervous System Drugs Table Distributors/Traders List Table Four basic brand strategies Table Industrial SWOT Analysis Table Global Central Nervous System Drugs Production Forecast by Regions (2016-2021) Table Global Central Nervous System Drugs Consumption Forecast by Regions (2016-2021) Table Global Central Nervous System Drugs Production Forecast by Type (2016-2021) Table Global Central Nervous System Drugs Consumption Forecast by Application (2016-2021)

Johnson & Johnson Pfizer Novartis Roche Sanofi-Aventis Merck GSK Bayer Schering Bristol-Myers Squibb AbbVie Eli Lilly AstraZeneca Takeda Actavis Astellas Pharma US Teva Biogen Shire